Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

GlaxoSmithKline (GSK) is investing $120 million to expand its manufacturing facility in Upper Merion, Pennsylvania to support the delivery of the company’s pipeline for cancer medicines and other specialty diseases. GSK says the new...

The US House of Representatives Speaker Nancy Pelosi (D-Calif.) has introduced a proposed drug pricing plan (H.R.3, The Lower Drug Costs Now Act) to address the cost of prescription drugs. The proposed legislation would establish a fair price...

US Senator Amy Klobuchar (D-MN), Ranking Member of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, and eight other senators, have sent a letter to US Federal Trade Commission (FTC) Chairman Joseph Simons...

H. Lundbeck, a Valby, Denmark-based pharmaceutical company, has agreed to acquire Alder Biopharmaceuticals, a Bothell, Washington-based clinical-stage biopharmaceutical company developing therapeutic antibodies for treating migraines, in a deal...

The US Food and Drug Administration (FDA) reports that it has found that some medicines with the active pharmaceutical ingredient (API), ranitidine, contain a nitrosamine impurity, N-nitrosodimethylamine (NDMA) at low levels. NDMA is classified as...